A Phase 2 study of Savolitinib in Patients with MET Amplified Metastatic Colorectal Cancer is a research paper published in Carolina Digital Repository (University of North Carolina at Chapel Hill) (2024). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 3P30CA014089-17S1
USC COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
National Institutes of Health
Grant: 5UM1CA186704-05
Duke-UNC-Wash U Partnership for Early Phase Clinical Trials in Cancer
National Institutes of Health
Grant: 2UM1CA186717-06
Phase 1 and 2 Molecular and Clinical Pharmacodynamic Trials ETCTN
FWCI
0.00
Citation Percentile
0.4%
Fields of Study
Keywords
Sustainable Development Goals